(Q40541785)

English

Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation

scientific article published on July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

zoledronic acid

1 reference

based on heuristic

inferred from title

author name string

Jonathan P Coxon

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Grenville M Oades

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Roger S Kirby

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kay W Colston

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

164-170

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Bisphosphonates induce apoptosis in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Rho as a regulator of the cytoskeleton.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Direct effects of bisphosphonates on breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Inhibitors of Ras farnesyltransferases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-4096.2004.04831.X

21 January 2018

Identifiers

10.1111/J.1464-4096.2004.04831.X

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40541785&oldid=1900116442"